Beckman buys point-of-care coagulation system:
This article was originally published in Clinica
Executive Summary
Beckman Coulter has bought a point-of-care system for prothrombin time testing from Avocet Medical in a $3 million deal. As a result, Beckman gets all rights to Avocet's hand-held point-of-care AvoSure system to monitor patients undergoing anticoagulation treatment. Beckman will begin selling the product, which it will manufacture at its own site, late this year. Beckman says the system's core fluorescence technology could be adapted for a range of test in the future. It also complements the lab-based coagulation system that Beckman distributes for Instrumentation Laboratories, the company says.